288 related articles for article (PubMed ID: 23775087)
21. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
22. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.
Uramoto H; Izumi H; Ise T; Tada M; Uchiumi T; Kuwano M; Yasumoto K; Funa K; Kohno K
J Biol Chem; 2002 Aug; 277(35):31694-702. PubMed ID: 12080043
[TBL] [Abstract][Full Text] [Related]
23. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
Sun XX; Wang YG; Xirodimas DP; Dai MS
J Biol Chem; 2010 Aug; 285(33):25812-21. PubMed ID: 20554519
[TBL] [Abstract][Full Text] [Related]
24. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Jung JH; Lee HJ; Kim JH; Sim DY; Im E; Kim S; Chang S; Kim SH
Cells; 2020 Apr; 9(4):. PubMed ID: 32316188
[TBL] [Abstract][Full Text] [Related]
25. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
Wang M; Hu Y; Amatangelo MD; Stearns ME
Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
[TBL] [Abstract][Full Text] [Related]
26. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
27. Ribosomal protein S14 of Saccharomyces cerevisiae regulates its expression by binding to RPS14B pre-mRNA and to 18S rRNA.
Fewell SW; Woolford JL
Mol Cell Biol; 1999 Jan; 19(1):826-34. PubMed ID: 9858605
[TBL] [Abstract][Full Text] [Related]
28. c-Myc modulates microRNA processing via the transcriptional regulation of Drosha.
Wang X; Zhao X; Gao P; Wu M
Sci Rep; 2013; 3():1942. PubMed ID: 23735886
[TBL] [Abstract][Full Text] [Related]
29. AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.
Vartanian R; Masri J; Martin J; Cloninger C; Holmes B; Artinian N; Funk A; Ruegg T; Gera J
Mol Cancer Res; 2011 Jan; 9(1):115-30. PubMed ID: 21135252
[TBL] [Abstract][Full Text] [Related]
30. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.
Lee H; Jung JH; Ko HM; Park H; Segall AM; Sheffmaker RL; Wang J; Frey WD; Pham N; Wang Y; Zhang Y; Jackson JG; Zeng SX; Lu H
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2308292120. PubMed ID: 38032932
[TBL] [Abstract][Full Text] [Related]
31. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.
Köenig A; Linhart T; Schlengemann K; Reutlinger K; Wegele J; Adler G; Singh G; Hofmann L; Kunsch S; Büch T; Schäfer E; Gress TM; Fernandez-Zapico ME; Ellenrieder V
Gastroenterology; 2010 Mar; 138(3):1189-99.e1-2. PubMed ID: 19900447
[TBL] [Abstract][Full Text] [Related]
32. RPS14 promotes the development and progression of glioma via p53 signaling pathway.
Hu S; Cai J; Fang H; Chen Z; Zhang J; Cai R
Exp Cell Res; 2023 Feb; 423(1):113451. PubMed ID: 36535509
[TBL] [Abstract][Full Text] [Related]
33. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
[TBL] [Abstract][Full Text] [Related]
34. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
35. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional repression of Myc underlies the tumour suppressor function of AGO1 in
Zaytseva O; Mitchell NC; Guo L; Marshall OJ; Parsons LM; Hannan RD; Levens DL; Quinn LM
Development; 2020 Jun; 147(11):. PubMed ID: 32527935
[TBL] [Abstract][Full Text] [Related]
37. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
[TBL] [Abstract][Full Text] [Related]
38. Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells.
Napoli S; Pastori C; Magistri M; Carbone GM; Catapano CV
EMBO J; 2009 Jun; 28(12):1708-19. PubMed ID: 19461583
[TBL] [Abstract][Full Text] [Related]
39. The C-terminus of nucleolin promotes the formation of the c-MYC G-quadruplex and inhibits c-MYC promoter activity.
González V; Hurley LH
Biochemistry; 2010 Nov; 49(45):9706-14. PubMed ID: 20932061
[TBL] [Abstract][Full Text] [Related]
40. PIWIL2 induces c-Myc expression by interacting with NME2 and regulates c-Myc-mediated tumor cell proliferation.
Yao Y; Li C; Zhou X; Zhang Y; Lu Y; Chen J; Zheng X; Tao D; Liu Y; Ma Y
Oncotarget; 2014 Sep; 5(18):8466-77. PubMed ID: 25193865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
